1-8 of 8
Reinhard G. Bretzel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2014;37(11):e247
https://doi.org/10.2337/dc14-1790
Published: 10 October 2014
View article titled, Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508
Open the PDF for Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508 in another window
Journal Articles

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2014;37(6):1499–1508
https://doi.org/10.2337/dc13-2743
Published: 10 May 2014
View article titled, Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
Open the PDF for Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? in another window
Journal Articles

How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment

Baptist Gallwitz, MD, Reinhard G. Bretzel, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S180–S189
https://doi.org/10.2337/dcS13-2012
Published: 17 July 2013
View article titled, How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment
Open the PDF for How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment in another window
Journal Articles

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond

Reinhard G. Bretzel, MD, PHD, Michael Eckhard, MD, Wolfgang Landgraf, PHD, David R. Owens, MD, FRCP, Thomas Linn, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(suppl_2):S260–S265
https://doi.org/10.2337/dc09-S319
Published: 01 November 2009
View article titled, Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: <subtitle>Basal or prandial insulin? The APOLLO trial and beyond</subtitle>
Open the PDF for Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: <subtitle>Basal or prandial insulin? The APOLLO trial and beyond</subtitle> in another window
Journal Articles

Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?

Philip D. Hardt, MD, PHD, Mathias D. Brendel, MD, Hans U. Kloer, MD, PHD, Reinhard G. Bretzel, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(Supplement_2):S165–S169
https://doi.org/10.2337/dc08-s244
Published: 01 February 2008
View article titled, Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?
Open the PDF for Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed? in another window
Journal Articles

Effects of Oral Fat Load on Insulin Output and Glucose Tolerance in Healthy Control Subjects and Obese Patients Without Diabetes

Oliver Wuesten, MD, Cristoph H. Balz, MD, Reinhard G. Bretzel, MD, Hans-Ulrich Kloer, MD, Philip D. Hardt, MD
Journal: Diabetes Care
Diabetes Care 2005;28(2):360–365
https://doi.org/10.2337/diacare.28.2.360
Published: 01 February 2005
View article titled, Effects of Oral Fat Load on Insulin Output and Glucose Tolerance in Healthy Control Subjects and Obese Patients Without Diabetes
Open the PDF for Effects of Oral Fat Load on Insulin Output and Glucose Tolerance in Healthy Control Subjects and Obese Patients Without Diabetes in another window
Journal Articles

A Direct Efficacy and Safety Comparison of Insulin Aspart, Human Soluble Insulin, and Human Premix Insulin (70/30) in Patients With Type 2 Diabetes

Reinhard G. Bretzel, MD, Sabine Arnolds, MD, Jürgen Medding, MSC, Thomas Linn, MD
Journal: Diabetes Care
Diabetes Care 2004;27(5):1023–1027
https://doi.org/10.2337/diacare.27.5.1023
Published: 01 May 2004
View article titled, A Direct Efficacy and Safety Comparison of Insulin Aspart, Human Soluble Insulin, and Human Premix Insulin (70/30) in Patients With Type 2 Diabetes
Open the PDF for A Direct Efficacy and Safety Comparison of Insulin Aspart, Human Soluble Insulin, and Human Premix Insulin (70/30) in Patients With Type 2 Diabetes in another window
Journal Articles

Comparative Analysis of Organ-Specific Autoantibodies and Celiac Disease—Associated Antibodies in Type 1 Diabetic Patients, Their First-Degree Relatives, and Healthy Control Subjects

Clemens Jaeger, MD, Erifili Hatziagelaki, MD, Rüdiger Petzoldt, MD, PHD, Reinhard G. Bretzel, MD, PHD
Journal: Diabetes Care
Diabetes Care 2001;24(1):27–32
https://doi.org/10.2337/diacare.24.1.27
Published: 01 January 2001
View article titled, Comparative Analysis of Organ-Specific Autoantibodies and Celiac Disease—Associated Antibodies in Type 1 Diabetic Patients, Their First-Degree Relatives, and Healthy Control Subjects
Open the PDF for Comparative Analysis of Organ-Specific Autoantibodies and Celiac Disease—Associated Antibodies in Type 1 Diabetic Patients, Their First-Degree Relatives, and Healthy Control Subjects in another window